Drug Shortage Report for TOVIAZ

Last updated on 2021-04-01 History
Report ID 135301
Drug Identification Number 02380048
Brand name TOVIAZ
Common or Proper name Toviaz
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) FESOTERODINE FUMARATE
Strength(s) 8MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30's
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-03-19
Actual start date
Estimated end date 2021-04-01
Actual end date 2021-03-31
Shortage status Resolved
Updated date 2021-04-01
Company comments Limited available inventory is on allocation until depletion on approx March 19th.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-04-01 English Compare
v7 2021-03-31 French Compare
v6 2021-03-31 English Compare
v5 2021-03-25 French Compare
v4 2021-03-25 English Compare
v3 2021-03-20 English Compare
v2 2021-03-08 French Compare
v1 2021-03-08 English Compare